History of myeloid-derived suppressor cells
Open accessThe DOI matches its Crossref record; 198 of the 199 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Myeloid-derived suppressor cells (MDSCs), a heterogeneous group of immune cells from the myeloid lineage, are a major component of the immunosuppressive TME [93].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
The cited source says what the claim attributes to it.
In the citing paper
“The TME is immunosuppressive, thus rendering the immune system less effective in killing cancer cells.”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Self-citationMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Goycoolea, A. (1997) · Cited by 3,615
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Self-citationMacrophages, innate immunity and cancer: balance, tolerance, and diversity
Mantovani, A., & Sica, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.009 · Cited by 1,484
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Self-citationImmune cell migration in inflammation: present and future therapeutic targets
Luster, A. D., Alon, R., & von Andrian, U. H. (2005) · Nature Immunology · doi:10.1038/ni1275 · Cited by 1,313
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Vincent, J., Mignot, G., Chalmin, F., Ladoire, S., Bruchard, M., Chevriaux, A., Martin, F., Apetoh, L., Rébé, C., & Ghiringhelli, F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3690 · Cited by 1,245
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Altered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., & Van Ginderachter, J. A. (2008) · Blood · doi:10.1182/blood-2007-07-099226 · Cited by 1,234
Diaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., & Montero, A. J. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0523-4 · Cited by 1,215
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Self-citationAACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,169
Self-citationYang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., VandenBerg, S., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,130
Granulocyte colony-stimulating factor and its receptor
Demetri, G., & Griffin, J. (1991) · Blood · doi:10.1182/blood.v78.11.2791.2791 · Cited by 1,064
Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., & Albelda, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0883 · Cited by 1,054
Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., & Carbone, D. P. (1998) · Blood · doi:10.1182/blood.v92.11.4150 · Cited by 1,048
Self-citation(1970) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/45.4.773 · Cited by 1,025
Bayne, L. J., Beatty, G. L., Jhala, N., Clark, C. E., Rhim, A. D., Stanger, B. Z., & Vonderheide, R. H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.025 · Cited by 947
Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.004 · Cited by 918
Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M., Nacken, W., Sorg, C., Vogl, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080132 · Cited by 902
Self-citationKo, J. S., Zea, A. H., Rini, B. I., Ireland, J. L., Elson, P., Cohen, P., Golshayan, A., Rayman, P. A., Wood, L., Garcia, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1332 · Cited by 862
Zea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D., Quiceno, D., Youmans, A., O'Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 851
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology · doi:10.1038/nbt1323 · Cited by 849
The Terminology Issue for Myeloid-Derived Suppressor Cells
Gabrilovich, D. I., Bronte, V., Chen, S.-H., Colombo, M. P., Ochoa, A., Ostrand-Rosenberg, S., & Schreiber, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3037 · Cited by 835
Self-citationGranulocyte colony-stimulating factor and its receptor
Demetri, G. D., & Griffin, J. (1991) · Blood · doi:10.1182/blood.v78.11.2791.bloodjournal78112791 · Cited by 825
Tumor heterogeneity and the biology of cancer invasion and metastasis.
Fidler, I. J. (1978) · PubMed · Cited by 818
The Biology of Cancer Invasion and Metastasis
(1978) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60648-x · Cited by 801
Li, H., Han, Y., Guo, Q., Zhang, M., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.240 · Cited by 777
Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., & Ochoa, A. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1921 · Cited by 773
Serafini, P., Meckel, K., Kelso, M., Noonan, K., Califano, J., Koch, W., Dolcetti, L., Bronte, V., & Borrello, I. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061104 · Cited by 766
Lévesque, J.-P., Hendy, J., Takamatsu, Y., Simmons, P. J., & Bendall, L. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15994 · Cited by 761
Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S., & Srikrishna, G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4666 · Cited by 725
(2000) · PubMed · Cited by 706
Clinical significance of defective dendritic cell differentiation in cancer.
Almand, B., Resser, J. R., Lindman, B. R., Nadaf, S., Clark, J. I., Kwon, E. D., Carbone, D. P., & Gabrilovich, D. I. (2000) · PubMed · Cited by 699
Self-citationMyeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 690
Preparing the “Soil”: The Premetastatic Niche
Kaplan, R. N., Rafii, S., & Lyden, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2407 · Cited by 665
Kowanetz, M., Wu, X., Lee, J., Tan, M., Hagenbeek, T., Qu, X., Yu, L., Ross, J., Korsisaari, N., Cao, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015855107 · Cited by 663
Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1
McQuibban, G. A., Butler, G. S., Gong, J.-H., Bendall, L., Power, C., Clark-Lewis, I., & Overall, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107736200 · Cited by 655
Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly-Scumpia, K. M., O'Malley, K. A., Wynn, J. L., Antonenko, S., Al-Quran, S. Z., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062602 · Cited by 652
Self-citationFilipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., Castelli, C., Mariani, L., Parmiani, G., & Rivoltini, L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5829 · Cited by 647
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.-H., Yao, J., Blanchard, D., Bais, C., Peale, F. V., van Bruggen, N., et al. (2007) · Nature · doi:10.1038/nature06348 · Cited by 644
Myeloid-derived suppressor cell heterogeneity and subset definition
Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., & Bronte, V. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.021 · Cited by 630
Karsunky, H., Merad, M., Cozzio, A., Weissman, I. L., & Manz, M. G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030323 · Cited by 602
Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Geilich, M., Winkels, G., Traggiai, E., Casati, A., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.200939903 · Cited by 569
Youn, J., & Gabrilovich, D. I. (2010) · European Journal of Immunology · doi:10.1002/eji.201040895 · Cited by 568
Self-citationFLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Fischer, C., Mazzone, M., Jonckx, B., & Carmeliet, P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2524 · Cited by 568
Mirza, N., Fishman, M., Fricke, I., Dunn, M., Neuger, A. M., Frost, T. J., Lush, R. M., Antonia, S., & Gabrilovich, D. I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1690 · Cited by 564
Self-citationMechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5398 · Cited by 538
Self-citationSerafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., & Borrello, I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0757 · Cited by 523
Role of organ selectivity in the determination of metastatic patterns of B16 melanoma.
Hart, I. R., & Fidler, I. J. (1980) · PubMed · Cited by 517
Youn, J.-I., Collazo, M., Shalova, I. N., Biswas, S. K., & Gabrilovich, D. I. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311177 · Cited by 510
Self-citationKodumudi, K. N., Woan, K., Gilvary, D. L., Sahakian, E., Wei, S., & Djeu, J. Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0733 · Cited by 500
Shojaei, F., Wu, X., Qu, X., Kowanetz, M., Yu, L., Tan, M., Meng, Y. G., & Ferrara, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902280106 · Cited by 471
Kusmartsev, S. A., Cheng, F., Yu, B., Nefedova, Y., Sotomayor, E. M., Lush, R. M., & Gabrilovich, D. I. (2003) · PubMed · Cited by 460
Self-citationAntonia, S. J., Mirza, N., Fricke, I., Chiappori, A., Thompson, P., Williams, N., Bepler, G., Simon, G., Janssen, W., Lee, J.-H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2013 · Cited by 444
Self-citationSchlecker, E., Stojanovic, A., Eisen, C., Quack, C., Falk, C. S., Umansky, V., & Cerwenka, A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201018 · Cited by 438
Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma
Huang, D., Ding, Y., Zhou, M., Rini, B. I., Petillo, D., Qian, C.-N., Kahnoski, R., Futreal, P. A., Furge, K. A., & Teh, B. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3965 · Cited by 417
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Nagaraj, S., Schrum, A. G., Cho, H.-I., Celis, E., & Gabrilovich, D. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902661 · Cited by 414
Self-citationBronte, V., Chappell, D. B., Apolloni, E., Cabrelle, A., Wang, M., Hwu, P., & Restifo, N. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5728 · Cited by 405
Myeloid derived suppressor cells in human diseases
Greten, T. F., Manns, M. P., & Korangy, F. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.003 · Cited by 398
Nolan, D. J., Ciarrocchi, A., Mellick, A. S., Jaggi, J. S., Bambino, K., Gupta, S., Heikamp, E., McDevitt, M. R., Scheinberg, D. A., Benezra, R., et al. (2007) · Genes & Development · doi:10.1101/gad.436307 · Cited by 394
Panopoulos, A. D., & Watowich, S. S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.03.002 · Cited by 394
Poschke, I., Mougiakakos, D., Hansson, J., Masucci, G. V., & Kiessling, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3767 · Cited by 382
Dumitru, C. A., Moses, K., Trellakis, S., Lang, S., & Brandau, S. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1294-5 · Cited by 374
Nishie, A., Ono, M., Shono, T., Fukushi, J., Otsubo, M., Onoue, H., Ito, Y., Inamura, T., 清信, 池., Fukui, M., et al. (1999) · PubMed · Cited by 369
Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice
Sawanobori, Y., Ueha, S., Kurachi, M., Shimaoka, T., Talmadge, J. E., Abe, J., Shono, Y., Kitabatake, M., Kakimi, K., Mukaida, N., et al. (2008) · Blood · doi:10.1182/blood-2008-01-136895 · Cited by 367
Self-citationPriceman, S. J., Sung, J. L., Shaposhnik, Z., Burton, J. B., Torres-Collado, A. X., Moughon, D. L., Johnson, M., Lusis, A. J., Cohen, D. A., Iruela-Arispe, M. L., et al. (2010) · Blood · doi:10.1182/blood-2009-08-237412 · Cited by 356
Kusmartsev, S. A., Li, Y., & Chen, S.-H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.779 · Cited by 355
Youn, J.-I., Kumar, V., Collazo, M., Nefedova, Y., Condamine, T., Cheng, P., Villagra, A., Antonia, S., McCaffrey, J. C., Fishman, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2526 · Cited by 350
Self-citationInhibition of tumor growth by elimination of granulocytes.
Pekarek, L. A., Starr, B. A., Toledano, A. Y., & Schreiber, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.435 · Cited by 340
Melani, C., Sangaletti, S., Barazzetta, F. M., Werb, Z., & Colombo, M. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1882 · Cited by 329
Pan, P.-Y., Wang, G. X., Yin, B., Ozao, J., Ku, T., Divino, C. M., & Chen, S.-H. (2008) · Blood · doi:10.1182/blood-2007-04-086835 · Cited by 319
Nefedova, Y., Nagaraj, S., Rosenbauer, A., Muro-Cacho, C., Sebti, S. M., & Gabrilovich, D. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0529 · Cited by 318
Self-citationBronte, V., Wang, M., Overwijk, W. W., Surman, D. R., Pericle, F., Rosenberg, S. A., & Restifo, N. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5313 · Cited by 312
duPre', S. A., & Hunter, K. W. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.06.007 · Cited by 309
Sade-Feldman, M., Kanterman, J., Ish-Shalom, E., Elnekave, M., Horwitz, E., & Baniyash, M. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.007 · Cited by 307
Role of β2-integrins for homing and neovascularization capacity of endothelial progenitor cells
Chavakis, E., Aicher, A., Heeschen, C., Sasaki, K.-I., Kaiser, R., El Makhfi, N., Urbich, C., Peters, T., Scharffetter-Kochanek, K., Zeiher, A. M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041402 · Cited by 304
Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal
Zon, L. I. (2008) · Nature · doi:10.1038/nature07038 · Cited by 296
Ko, J. S., Rayman, P., Ireland, J., Swaidani, S., Li, G., Bunting, K. D., Rini, B., Finke, J. H., & Cohen, P. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3278 · Cited by 296
Melani, C., Chiodoni, C., Forni, G., & Colombo, M. P. (2003) · Blood · doi:10.1182/blood-2003-01-0190 · Cited by 295
Song, X., Krelin, Y., Dvorkin, T., Bjorkdahl, O., Segal, S., Dinarello, C. A., Voronov, E., & Apte, R. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8200 · Cited by 290
Lévesque, J.-P., Hendy, J., Takamatsu, Y., Williams, B., Winkler, I. G., & Simmons, P. J. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00788-9 · Cited by 289
Talmadge, J. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0182 · Cited by 285
Self-citationDe Santo, C., Serafini, P., Marigo, I., Dolcetti, L., Bolla, M., Del Soldato, P., Melani, C., Guiducci, C., Colombo, M. P., Iezzi, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409783102 · Cited by 284
MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
Finke, J., Ko, J., Rini, B., Rayman, P., Ireland, J., & Cohen, P. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.030 · Cited by 281
Macrophage Infiltration and Heme Oxygenase-1 Expression Correlate with Angiogenesis in Human Gliomas
西江, 昭. (2001) · Medical Entomology and Zoology · doi:10.11501/3181003 · Cited by 278
Porembka, M. R., Mitchem, J. B., Belt, B. A., Hsieh, C.-S., Lee, H.-M., Herndon, J., Gillanders, W. E., Linehan, D. C., & Goedegebuure, P. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1178-0 · Cited by 277
Liu, Y., Lai, L., Chen, Q., Song, Y., Xu, S., Ma, F., Wang, X., Wang, J., Yu, H., Cao, X., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103505 · Cited by 272
Pak, A. S., Wright, M. A., Matthews, J. P., Collins, S. L., Petruzzelli, G. J., & Young, M. R. I. (1995) · PubMed · Cited by 271
Price, T., Chatta, G., & Dale, D. (1996) · Blood · doi:10.1182/blood.v88.1.335.335 · Cited by 271
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
Zhang, J., Patel, L., & Pienta, K. J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.009 · Cited by 261
Wang, L., Chang, E. W. Y., Wong, S. C., Ong, S.-M., Chong, D. Q. Y., & Ling, K. L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202088 · Cited by 251
Tumor-Induced Immune Dysfunctions Caused by Myeloid Suppressor Cells
Bronte, V., Serafini, P., Apolloni, E., & Zanovello, P. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200111000-00001 · Cited by 250
Forrester, E., Chytil, A., Bierie, B., Aakre, M., Gorska, A. E., Sharif-Afshar, A.-R., Muller, W. J., & Moses, H. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3272 · Cited by 249
Waight, J. D., Hu, Q., Miller, A., Liu, S., & Abrams, S. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027690 · Cited by 246
Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
Filipazzi, P., Huber, V., & Rivoltini, L. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1161-9 · Cited by 243
A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature
Jin, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24751 · Cited by 225
Myeloid-Derived Suppressor Cells in Human Cancer
Nagaraj, S., & Gabrilovich, D. I. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181eb3358 · Cited by 223
Self-citationS100A9 a new marker for monocytic human myeloid‐derived suppressor cells
Zhao, F., Hoechst, B., Duffy, A., Gamrekelashvili, J., Fioravanti, S., Manns, M. P., Greten, T. F., & Korangy, F. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03566.x · Cited by 221
Morales, J. K., Kmieciak, M., Knutson, K. L., Bear, H. D., & Manjili, M. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0622-8 · Cited by 214
Granulocyte Colony-Stimulating Factor: A Novel Mediator of T Cell Tolerance
Rutella, S., Zavala, F., Danese, S., Kared, H., & Leone, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7085 · Cited by 208
Myeloid-derived Suppressor Cells in Cancer Patients: A Clinical Perspective
Montero, A. J., Diaz-Montero, C. M., Kyriakopoulos, C. E., Bronte, V., & Mandruzzato, S. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318242169f · Cited by 202
Davidoff, A. M., Ng, C. Y., Brown, P. D. N., Leary, M. A., Spurbeck, W. W., Zhou, J., Horwitz, E., Vanin, E. F., & Nienhuis, A. W. (2001) · PubMed · Cited by 201
Mielcarek, M., Martin, P. J., & Torok-Storb, B. (1997) · Blood · doi:10.1182/blood.v89.5.1629 · Cited by 196
CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice
Si, Y., Tsou, C.-L., Croft, K., & Charo, I. F. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40310 · Cited by 186
Dome, B., Timar, J., Dobos, J., Meszaros, L., Raso, E., Paku, S., Kenessey, I., Ostoros, G., Magyar, M., Ladanyi, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4654 · Cited by 184
Fricke, I., Mirza, N., Dupont, J., Lockhart, C., Jackson, A., Lee, J.-H., Sosman, J. A., & Gabrilovich, D. I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0409 · Cited by 182
Self-citationSasmono, R. T., Ehrnsperger, A., Cronau, S. L., Ravasi, T., Kandane, R., Hickey, M. J., Cook, A. D., Himes, S. R., Hamilton, J. A., & Hume, D. A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1206713 · Cited by 182
Johns, J. L., & Christopher, M. M. (2012) · Veterinary Pathology · doi:10.1177/0300985811432344 · Cited by 181
On the armament and appearances of human myeloid-derived suppressor cells
Poschke, I., & Kiessling, R. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.06.003 · Cited by 177
Subsets, expansion and activation of myeloid-derived suppressor cells
Ribechini, E., Greifenberg, V., Sandwick, S., & Lutz, M. B. (2010) · Medical Microbiology and Immunology · doi:10.1007/s00430-010-0151-4 · Cited by 177
Robinson, W. A. (1974) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1974.tb14451.x · Cited by 167
Xu, L., Duda, D. G., di Tomaso, E., Ancukiewicz, M., Chung, D. C., Lauwers, G. Y., Samuel, R., Shellito, P., Czito, B. G., Lin, P.-C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2099 · Cited by 161
Brandau, S., Moses, K., & Lang, S. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.007 · Cited by 159
Immune Suppression with Supraoptimal Doses of Antigen in Contact Sensitivity
Sy, M., Miller, S. D., & Claman, H. N. (1977) · The Journal of Immunology · doi:10.4049/jimmunol.119.1.240 · Cited by 148
Mundy, G. R. (2008) · Bone · doi:10.1016/j.bone.2007.12.198 · Cited by 147
Resection of Solid Tumors Reverses T Cell Defects and Restores Protective Immunity
Salvadori, S., Martinelli, G., & Zier, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2214 · Cited by 142
Young, M. R., Wright, M. A., Matthews, J. P., Malik, I., & Prechel, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1916 · Cited by 142
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
Talmadge, J. E., Hood, K. C., Zobel, L., Shafer, L. R., Coles, M., & Tóth, B. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.09.021 · Cited by 139
Self-citationSy, M., Miller, S. D., & Claman, H. N. (1977) · PubMed · Cited by 139
van Cruijsen, H., van der Veldt, A. A. M., Vroling, L., Oosterhoff, D., Broxterman, H. J., Scheper, R. J., Giaccone, G., Haanen, J. B. A. G., van den Eertwegh, A. J. M., Boven, E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0656 · Cited by 135
Functional differentiation of normal human neutrophils
Glasser, L., & Fiederlein, R. (1987) · Blood · doi:10.1182/blood.v69.3.937.937 · Cited by 133
Sun, H.-L., Xin Min, Z. H. O. U., Xue, Y., Wang, K., Shen, Y., Mao, J., Guo, H., & Miao, Z. (2012) · PubMed · doi:10.3748/wjg.v18.i25.3303 · Cited by 128
Integrin α4β1 Promotes Monocyte Trafficking and Angiogenesis in Tumors
Jin, H., Su, J., Garmy-Susini, B., Kleeman, J., & Varner, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2704 · Cited by 127
Sumida, K., Wakita, D., Narita, Y., Masuko, K., Terada, S., Watanabe, K., Satoh, T., Kitamura, H., & Nishimura, T. (2012) · European Journal of Immunology · doi:10.1002/eji.201142335 · Cited by 126
Rashid, O. M., Nagahashi, M., Ramachandran, S., Graham, L., Yamada, A., Spiegel, S., Bear, H. D., & Takabe, K. (2013) · Surgery · doi:10.1016/j.surg.2013.02.002 · Cited by 126
Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells.
Bennett, J. A., Rao, V. S., & Mitchell, M. S. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5142 · Cited by 125
CD49d Is a New Marker for Distinct Myeloid-Derived Suppressor Cell Subpopulations in Mice
Haile, L. A., Gamrekelashvili, J., Manns, M. P., Korangy, F., & Greten, T. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903573 · Cited by 119
Li, B., Vincent, A., Cates, J., Brantley-Sieders, D. M., Polk, D. B., & Young, P. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1565 · Cited by 115
Laoui, D., Overmeire, E. V., Movahedi, K., den Bossche, J. V., Schouppe, E., Mommer, C., Nikolaou, A., Morias, Y., BAETSELIER, P. D., & Ginderachter, J. A. V. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.06.007 · Cited by 112
Tsuchiya, Y., Igarashi, M., Suzuki, R., & Kumagai, K. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.2.699 · Cited by 110
Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells
Donkor, M. K., Lahue, E. E., Hoke, T. A., Shafer, L. R., Çoşkun, U., Solheim, J. C., Gülen, D., Bishay, J., & Talmadge, J. E. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.03.021 · Cited by 106
Self-citationConnolly, M. K., Mallen-St. Clair, J., Bedrosian, A. S., Malhotra, A., Vera, V., Ibrahim, J., Henning, J., Pachter, H. L., Bar-Sagi, D., Frey, A. B., et al. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0909607 · Cited by 104
Okazaki, T., Ebihara, S., Asada, M., Kanda, A., Sasaki, H., & Yamaya, M. (2005) · International Immunology · doi:10.1093/intimm/dxh334 · Cited by 104
Oseroff, A. R., Okada, S., & Strober, S. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.3.1585.b · Cited by 103
Mukherjee, P., Basu, G. D., Tinder, T. L., Subramani, D. B., Bradley, J. M., Arefayene, M., Skaar, T. C., & Petris, G. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.216 · Cited by 98
Wu, L., Yan, C., Czader, M., Foreman, O., Blum, J. S., Kapur, R., & Du, H. (2012) · Blood · doi:10.1182/blood-2011-06-363093 · Cited by 93
Oseroff, A. R., Okada, S., & Strober, S. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.1.101 · Cited by 92
Talmadge, J. E., Reed, E. C., Kessinger, A., KUSZYNSKI, C. A., Perry, G. A., Gordy, C. L., Mills, K., Thomas, M. L., Pirruccello, S. J., Letheby, B., et al. (1996) · PubMed · Cited by 88
Self-citationJin, F., Zhai, Q.-L., Qiu, L., Meng, H., Zou, D., Wang, Y., Li, Q., Yu, Z., Han, J., Li, Q., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.222 · Cited by 82
Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells
Younos, I., Donkor, M. K., Hoke, T. A., Dafferner, A. J., Samson, H., Westphal, S. N., & Talmadge, J. E. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.02.021 · Cited by 79
Self-citationMulligan, J. K., Rosenzweig, S. A., & Young, M. R. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181b91c9c · Cited by 79
Pruijt, J. F. M., van Kooyk, Y., Figdor, C. G., Lindley, I. J. D., Willemze, R., & Fibbe, W. E. (1998) · Blood · doi:10.1182/blood.v91.11.4099 · Cited by 77
Slavin, S., & Strober, S. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.2.942 · Cited by 77
Kyo, S., Kanaya, T., Takakura, M., & Inoue, M. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5904 · Cited by 75
The effect of zoledronic acid on the function and differentiation of myeloid cells.
Wolf, A. M., Rumpold, H. F., Tilg, H., Gastl, G. A., Gunsilius, E., & Wolf, D. G. F. (2006) · PubMed · Cited by 74
Chornoguz, O., Grmai, L., Sinha, P., Artemenko, K. A., Zubarev, R. A., & Ostrand-Rosenberg, S. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002980 · Cited by 69
Watson, G. A., Fu, Y., & Lopez, D. M. (1991) · Journal of Leukocyte Biology · doi:10.1002/jlb.49.2.126 · Cited by 67
Natural history of gastric adenomas in patients with familial adenomatosis Coli/Gardner's syndrome
Iida, M., Yao, T., Itoh, H., Watanabe, H., Matsui, T., Iwashita, A., & Fujishima, M. (1988) · Cancer · doi:10.1002/1097-0142(19880201)61:3<593::aid-cncr2820610329>3.0.co;2-z · Cited by 66
Watanabe, T., Davé, B. J., Heimann, D., Lethaby, E., Kessinger, A., & Talmadge, J. E. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700814 · Cited by 64
Self-citationMadlambayan, G. J., Butler, J. M., Hosaka, K., Jorgensen, M., Fu, D., Guthrie, S. M., Shenoy, A. K., Brank, A., Russell, K. J., Otero, J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211342 · Cited by 60
Young, M. R. I., & Wright, M. A. (1992) · PubMed · Cited by 59
Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice
Abe, F., Dafferner, A. J., Donkor, M. K., Westphal, S. N., Scholar, E. M., Solheim, J. C., Singh, R. K., Hoke, T. A., & Talmadge, J. E. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0719-2 · Cited by 58
Self-citationYoung, M. R., Wright, M. A., & Young, M. E. (1991) · Cancer Immunology Immunotherapy · doi:10.1007/bf01756134 · Cited by 57
Tricks tumors use to escape from immune control
Whiteside, T. L. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2009.03.006 · Cited by 57
Predina, J. D., Kapoor, V., Judy, B. F., Cheng, G., Fridlender, Z. G., Albelda, S. Μ., & Singhal, S. K. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-34 · Cited by 56
Gibb, D. R., Saleem, S. J., Kang, D.-J., Subler, M. A., & Conrad, D. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003318 · Cited by 53
Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase
Ellies, L. G., Fishman, M., Hardison, J., Kleeman, J., Maglione, J. E., Manner, C. K., Cardiff, R. D., & MacLeod, C. L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11178 · Cited by 52
Neutrophil Homeostasis: A New Role for Stromal Cell–Derived Factor-1
Link, D. C. (2005) · Immunologic Research · doi:10.1385/ir:32:1-3:169 · Cited by 51
Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking
Younos, I., Dafferner, A. J., Gülen, D., Britton, H. C., & Talmadge, J. E. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.05.002 · Cited by 49
Self-citationWanebo, H. J., Riley, T. A., Katz, D., Pace, R. C., Johns, M. E., & Cantrell, R. W. (1988) · Cancer · Cited by 49
Circulating stem cells in mice treated with cyclophosphamide
Craddock, C., Apperley, J., Wright, E. G., Healy, L. E., Bennett, C., Evans, M., Grimsley, P., & Gordon, M. Y. (1992) · Blood · doi:10.1182/blood.v80.1.264.bloodjournal801264 · Cited by 47
The immunoregulatory role of bone marrow
Duwe, A. K., & Singhal, S. K. (1979) · Cellular Immunology · doi:10.1016/0008-8749(79)90180-1 · Cited by 47
Young, M. R. I., Kolesiak, K., Wright, M. A., & Gabrilovich, D. I. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006708607666 · Cited by 46
Self-citationFas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation.
Singh, R. K., Varney, M. L., Büyükberber, S., Ino, K., Ageitos, A., Reed, E., Tarantolo, S., & Talmadge, J. E. (1999) · PubMed · Cited by 45
Self-citationBoutté, A. M., McDonald, W. H., Shyr, Y., Li, Y., & Lin, P. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022446 · Cited by 43
Characterization of iNOS+ Neutrophil-like ring cell in tumor-bearing mice
Virtuoso, L. P., Harden, J. L., Sotomayor, P. C., Sigurdson, W. J., Yoshimura, F., Egilmez, N. K., Minev, B., & Kilinc, M. O. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-152 · Cited by 41
A STUDY OF THE LEUKEMOID RESPONSE TO TRANSPLANTABLE A-280 TUMOR IN MICE.
LAPPAT, E. J., & Cawein, M. (1964) · PubMed · Cited by 38
Young, M. R., Young, M. E., & Wright, M. A. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460217 · Cited by 37
Solheim, J. C., Reber, A. J., Ashour, A. E., Robinson, S., Futakuchi, M., Kurz, S. G., Hood, K. C., Fields, R. R., Shafer, L. R., Cornell, D., et al. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701018 · Cited by 36
Self-citationLee, M. Y., & Rosse, C. (1982) · PubMed · Cited by 36
Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors.
Young, M. R., Young, M. E., & Wright, M. A. (1990) · PubMed · Cited by 33
Pruijt, H., Willemze, R., & Fibbe, W. E. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199905000-00005 · Cited by 29
Hooper, D. C., Hoskin, D. W., GRÖNVIK, K. ‐., & Murgita, R. A. (1986) · Cellular Immunology · doi:10.1016/0008-8749(86)90254-6 · Cited by 29
Stenvold, H., Dønnem, T., Andersen, S., Al‐Saad, S., Al-Shibli, K. I., Busund, L., & Bremnes, R. M. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.06.010 · Cited by 27
The Terminology Issue for Myeloid-Derived Suppressor Cells
Yang, R., & Roden, R. B. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3630 · Cited by 27
Heterogeneity of splenic natural suppressor cells induced in mice by treatment with cyclophosphamide
Brooks-Kaiser, J. C., Bourque, L. A., & Hoskin, D. W. (1993) · Immunopharmacology · doi:10.1016/0162-3109(93)90015-i · Cited by 26
Lathers, D. M. R., Clark, J. I., Achille, N. J., & Young, M. R. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00317-2 · Cited by 26
Mauro, E., Rigolin, G. M., Fraulini, C., Sofritti, O., Ciccone, M., Angeli, C. D., Castoldi, G., & Cuneo, A. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00831.x · Cited by 23
Young, M. R., Halpin, J., Wang, J., Wright, M. A., Matthews, J., & Pak, A. S. (1993) · PubMed · Cited by 21
Choi, K. L., Maier, T., Holda, J. H., & Claman, H. N. (1988) · Cellular Immunology · doi:10.1016/0008-8749(88)90297-3 · Cited by 20
Balwit, J. M., Hwu, P., Urba, W. J., & Marincola, F. M. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-18 · Cited by 17
Inhibition of the graft-versus-host response by BCGcw-induced suppressor cells or prostaglandin E1
Wren, S. M., Wepsic, H. T., Larson, C., Silva, M. A. D., & Mizushima, Y. (1983) · Cellular Immunology · doi:10.1016/0008-8749(83)90379-9 · Cited by 16
Bennett, J. A., & Mitchell, M. S. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90649-x · Cited by 14
Research works printed but not linked: 2
- Sonnenfeld, A. Leukamische reaktiones bei carcinoma. Zeitschrift f Klin Med 111, 108 (in German) (1929).
- Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled wth 1251-5-lodo-2′-deoxyuridine1,2,3. J. Natl Cancer Inst. 45, 773–782 (1970).
Cited by
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Self-citationMao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
“MDSCs mainly contain two cell subsets, termed polymorphonuclear MDSCs (PMN-MDSCs) and monocytic MDSCs (M-MDSCs), which are phenotypically and morphologically similar to neutrophils and monocytes, respectively [235, 236].”
BackgroundThe Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008
Self-citation
Metadata
- Authors
- Talmadge, J. E., & Gabrilovich, D. I.
- Affiliations
- University of Nebraska Medical Center (US)
- The Wistar Institute (US)
- Corresponding author
- Talmadge, James E.
- Venue
- Nature Reviews Cancer
- Published
- 2013-09-24
- Volume
- 13
- Issue
- 10
- Pages
- 739-752
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4358792
- OpenAlex
- W2122403898
- Cited by
- 1,148
- References
- 197
- Citations by year
- 2026: 29 · 2025: 57 · 2024: 80 · 2023: 74 · 2022: 105 · 2021: 132 · 2020: 110 · 2019: 95 · 2018: 101 · 2017: 90 · 2016: 129 · 2015: 93 · 2014: 43 · 2013: 7
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA084488, R01CA100062)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- myeloid-derived suppressor cells, tumor microenvironment, T cell suppression, immune evasion, tumor progression, metastasis, multipotent progenitors
- MeSH terms
- Animals, Antigens, Differentiation, Antigens, Neoplasm, Cell Differentiation, Cell Biology, Hematopoiesis, Extramedullary, Humans, Leukemoid Reaction, Medical Oncology, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Chemokines, Cell Lineage, Tumor Escape, Hematopoietic Stem Cell Mobilization, Myeloid Cells, Myeloid Progenitor Cells, Multipotent Stem Cells, Tumor Burden, History, 20th Century, History, 21st Century, Mice, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.